Lee Ainslie’s Cidara Therapeutics CDTX Stock Holding History

Lee Ainslie’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-455,978	Closed	-$101M	–	259
2025 Q4	$101M	Buy	455,978 +38,428	+9%	+$6.21M	1.08%	32
2025 Q3	$40M	Buy	+417,550	New	+$26.6M	0.53%	47

Lee Ainslie's CDTX Position: Q1 2026 in Review

Lee Ainslie sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 455,978 shares — an estimated $101M sold.

Lee Ainslie first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $101M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Lee Ainslie reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Lee Ainslie sold 455,978 Cidara Therapeutics shares in Q1 2026, an estimated $101M.
Lee Ainslie first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
Lee Ainslie's Cidara Therapeutics position peaked at $101M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Maverick Capital's 13F filing for Q1 2026, filed 15 May 2026.